Severe hemophagocytic syndrome after intravesical BCG instillation with a fatal outcome
Introduction. Hemophagocytic syndrome (HS) after Bacillus Calmette-Guérin (BCG) immunotherapy is extremely rare in everyday practice. Only three cases of HS have been reported in the world until now. BCG is used for preventing the recurrence of superficial tumors of the urinary bladder. Severe compl...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Military Health Department, Ministry of Defance, Serbia
2023-01-01
|
| Series: | Vojnosanitetski Pregled |
| Subjects: | |
| Online Access: | https://doiserbia.nb.rs/img/doi/0042-8450/2023/0042-84502200065S.pdf |
| _version_ | 1797807516776660992 |
|---|---|
| author | Stojanović Stevan Vojinov Saša Dimitrić Žarko Levakov Ivan Jeremić Dimitrije Lakić Tanja |
| author_facet | Stojanović Stevan Vojinov Saša Dimitrić Žarko Levakov Ivan Jeremić Dimitrije Lakić Tanja |
| author_sort | Stojanović Stevan |
| collection | DOAJ |
| description | Introduction. Hemophagocytic syndrome (HS) after Bacillus Calmette-Guérin (BCG) immunotherapy is extremely rare in everyday practice. Only three cases of HS have been reported in the world until now. BCG is used for preventing the recurrence of superficial tumors of the urinary bladder. Severe complications after BCG immunotherapy are rarely seen. Case report. A 55-year-old patient was transferred to the Clinic for Urology after the second round of BCG immunotherapy, in bad condition, after transurethral resection of a bladder tumor. Computed tomography of the abdomen and lesser pelvis was performed, which did not indicate any clear signs of organ failure or disease. Antitubercular, antibiotic, corticosteroid, and symptomatic therapies were applied. The achieved effect of therapy was not satisfactory. HS after BCG immunotherapy was suspected. During further hospitalization, the patient’s already severe condition further deteriorated and became more complicated in the form of multiorgan dysfunction syndrome. Death occurred on the sixth day of hospitalization. A urine culture test was performed post-mortem and three months later, it was positive for Mycobacterium xenopi. Conclusion. Secondary HS after BCG immunotherapy is an extremely rare disease accompanied by a severe general condition of the patient, with many life-threatening complications that can lead to death. We have presented a case of severe HS after BCG immunotherapy that caused the death of the patient. This case was unique because, for the first time, the possible causative agent was isolated – Mycobacteria. |
| first_indexed | 2024-03-13T06:23:44Z |
| format | Article |
| id | doaj.art-6648b8db755b4e0585eb8bad02cf600e |
| institution | Directory Open Access Journal |
| issn | 0042-8450 2406-0720 |
| language | English |
| last_indexed | 2024-03-13T06:23:44Z |
| publishDate | 2023-01-01 |
| publisher | Military Health Department, Ministry of Defance, Serbia |
| record_format | Article |
| series | Vojnosanitetski Pregled |
| spelling | doaj.art-6648b8db755b4e0585eb8bad02cf600e2023-06-09T10:45:01ZengMilitary Health Department, Ministry of Defance, SerbiaVojnosanitetski Pregled0042-84502406-07202023-01-0180544644910.2298/VSP210412065S0042-84502200065SSevere hemophagocytic syndrome after intravesical BCG instillation with a fatal outcomeStojanović Stevan0https://orcid.org/0000-0002-9067-7933Vojinov Saša1Dimitrić Žarko2Levakov Ivan3Jeremić Dimitrije4Lakić Tanja5https://orcid.org/0000-0003-4246-5132University Clinical Center of Vojvodina, Clinic for Urology, Novi Sad, Serbia + University of Novi Sad, Faculty of Medicine, Novi Sad, SerbiaUniversity Clinical Center of Vojvodina, Clinic for Urology, Novi Sad, Serbia + University of Novi Sad, Faculty of Medicine, Novi Sad, SerbiaUniversity Clinical Center of Vojvodina, Clinic for Urology, Novi Sad, SerbiaUniversity Clinical Center of Vojvodina, Clinic for Urology, Novi Sad, Serbia + University of Novi Sad, Faculty of Medicine, Novi Sad, SerbiaUniversity Clinical Center of Vojvodina, Clinic for Urology, Novi Sad, Serbia + University of Novi Sad, Faculty of Medicine, Novi Sad, SerbiaUniversity of Novi Sad, Faculty of Medicine, Novi Sad, Serbia + University Clinical Center of Vojvodina, Center for Pathology and Histology, Novi Sad, SerbiaIntroduction. Hemophagocytic syndrome (HS) after Bacillus Calmette-Guérin (BCG) immunotherapy is extremely rare in everyday practice. Only three cases of HS have been reported in the world until now. BCG is used for preventing the recurrence of superficial tumors of the urinary bladder. Severe complications after BCG immunotherapy are rarely seen. Case report. A 55-year-old patient was transferred to the Clinic for Urology after the second round of BCG immunotherapy, in bad condition, after transurethral resection of a bladder tumor. Computed tomography of the abdomen and lesser pelvis was performed, which did not indicate any clear signs of organ failure or disease. Antitubercular, antibiotic, corticosteroid, and symptomatic therapies were applied. The achieved effect of therapy was not satisfactory. HS after BCG immunotherapy was suspected. During further hospitalization, the patient’s already severe condition further deteriorated and became more complicated in the form of multiorgan dysfunction syndrome. Death occurred on the sixth day of hospitalization. A urine culture test was performed post-mortem and three months later, it was positive for Mycobacterium xenopi. Conclusion. Secondary HS after BCG immunotherapy is an extremely rare disease accompanied by a severe general condition of the patient, with many life-threatening complications that can lead to death. We have presented a case of severe HS after BCG immunotherapy that caused the death of the patient. This case was unique because, for the first time, the possible causative agent was isolated – Mycobacteria.https://doiserbia.nb.rs/img/doi/0042-8450/2023/0042-84502200065S.pdfbcg vaccinelymphohistiocytosis, hemophagocyticmultiple organ failuremycobacterium xenopiurologic surgical procedures |
| spellingShingle | Stojanović Stevan Vojinov Saša Dimitrić Žarko Levakov Ivan Jeremić Dimitrije Lakić Tanja Severe hemophagocytic syndrome after intravesical BCG instillation with a fatal outcome Vojnosanitetski Pregled bcg vaccine lymphohistiocytosis, hemophagocytic multiple organ failure mycobacterium xenopi urologic surgical procedures |
| title | Severe hemophagocytic syndrome after intravesical BCG instillation with a fatal outcome |
| title_full | Severe hemophagocytic syndrome after intravesical BCG instillation with a fatal outcome |
| title_fullStr | Severe hemophagocytic syndrome after intravesical BCG instillation with a fatal outcome |
| title_full_unstemmed | Severe hemophagocytic syndrome after intravesical BCG instillation with a fatal outcome |
| title_short | Severe hemophagocytic syndrome after intravesical BCG instillation with a fatal outcome |
| title_sort | severe hemophagocytic syndrome after intravesical bcg instillation with a fatal outcome |
| topic | bcg vaccine lymphohistiocytosis, hemophagocytic multiple organ failure mycobacterium xenopi urologic surgical procedures |
| url | https://doiserbia.nb.rs/img/doi/0042-8450/2023/0042-84502200065S.pdf |
| work_keys_str_mv | AT stojanovicstevan severehemophagocyticsyndromeafterintravesicalbcginstillationwithafataloutcome AT vojinovsasa severehemophagocyticsyndromeafterintravesicalbcginstillationwithafataloutcome AT dimitriczarko severehemophagocyticsyndromeafterintravesicalbcginstillationwithafataloutcome AT levakovivan severehemophagocyticsyndromeafterintravesicalbcginstillationwithafataloutcome AT jeremicdimitrije severehemophagocyticsyndromeafterintravesicalbcginstillationwithafataloutcome AT lakictanja severehemophagocyticsyndromeafterintravesicalbcginstillationwithafataloutcome |